ONKURE THERAPEUTICS
OnKure is a biotechnology company that commercializes a new cancer therapy based on novel, less toxic kinase inhibitor drugs. The company is engaged in the discovery and development of epigenetic therapies for the treatment of cancer that includes selective inhibitors of histone deacetylases. In pre-clinical models of both hematological and solid tumor cancers, their lead candidate, OKI-179, significantly and safely reduces the growth rate of tumors when dosed by itself or in combination with ot... her targeted therapies. OnKure advances the HDAC3 selective inhibitor OKI-422 into pre-clinical toxicology studies. The company's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
ONKURE THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
2011-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.onkuretherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
720-307-2892
Email Addresses:
[email protected]
Total Funding:
67.49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Immusoft
Immusoft, a biotechnology company, commercializes technologies that program the human immune system by modifying the DNA in related cells.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Tyra Biosciences
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Employees Featured
Founder
Investors List
Surveyor Capital
Surveyor Capital investment in Series B - OnKure Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series B - OnKure Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - OnKure Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - OnKure Therapeutics
Acorn Bioventures
Acorn Bioventures investment in Series B - OnKure Therapeutics
Delian Capital
Delian Capital investment in Series A - OnKure Therapeutics
OnKure management
OnKure management investment in Series A - OnKure Therapeutics
Key Employee Changes
Official Site Inspections
http://www.onkuretherapeutics.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: wpx.net
- IP address: 194.1.147.99
- Location: Chicago United States
- Latitude: 41.8719
- Longitude: -87.6589
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60607
